- Home
- SXTP vs OMH Comparison
SXTP vs OMH Comparison
Compare SXTP & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SXTP | OMH |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0M | 3.2M |
| IPO Year | 2023 | 2022 |
Fundamental Metrics
Financial Performance| Metric | SXTP | OMH |
|---|---|---|
| Price | $1.13 | $0.09 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $14.10 | N/A |
| AVG Volume (30 Days) | 78.2K | ★ 37.7M |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,005,471.00 | N/A |
| Revenue This Year | $33.92 | $28.40 |
| Revenue Next Year | $51.35 | $23.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 65.49 | N/A |
| 52 Week Low | $0.34 | $0.07 |
| 52 Week High | $8.62 | $2.19 |
Technical Indicators
Market Signals| Indicator | SXTP | OMH |
|---|---|---|
| Relative Strength Index (RSI) | 38.50 | 38.62 |
| Support Level | $1.07 | $0.07 |
| Resistance Level | $1.26 | $0.18 |
| Average True Range (ATR) | 0.09 | 0.02 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 46.15 | 24.00 |
Price Performance
Historical ComparisonAbout SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, Digital Marketing Services, and emerging and other services. The firm operates in two segments, which are Brokerage, emerging and another related service; and Estate management services and other related services in Singapore.